最新发布

Adcendo inks MSD supply deal to run ADC-Keytruda combination study

Copenhagen-based Adcendo plans to start a Phase Ib trial of the combination in the second half of the year. Participants will receive ADCE-T02, Adcendo’s tissue factor (TF)-directed ADC, with the anti-PD-1 checkpoint inhibitor Keytruda. Adcendo, which will sponsor the trial, began a Phase I monotherapy trial of ADCE-T02 in 2024. 

四川省推进化工园区安全整治提升行动

大农化网报道:5月20日,从四川省应急管理厅传出消息,四川省持续深化化工园区安全整治提升行动,通过资金加持、专家帮扶、智能赋能、标准引领等多项举措,全省化工园区本质安全水平与综合治理能力显著提升,目前已有35个化工园区成功达到D级低风险等级…

Zoomlion opens Latin America hub

The new center integrates product display, technical training, after-sales support, maintenance services, and customer experience, aiming to build a comprehensive service platform covering the entire Latin American market. As a key strategic hub for the region, it will showcase agricultural equipment and a complete spare parts system while providing localized and professional lifecycle support services.

Strait of Hormuz: Time Running out to Avert Global Food Security Crisis, FAO Warns

May 2026, Rome: The actions taken now will be critical in determining whether the world can manage the shock caused by t…

Three in One Go: LimmaTech, Curevo, Vaccine Company

With these three acquisitions, Eli Lilly and Company is significantly expanding its infectious disease activities. From a European perspective, the centrepiece is clearly the acquisition of LimmaTech Biologics in Schlieren near Zurich. Lilly will pay up to US$780 million for the clinical-stage vaccine company, including milestone-based payments.

Triple Play: Lilly Acquires Three Developers of Infectious Disease Vaccines for Up-to-$3.8B

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up to $3.83 billion cash, the companies said today, in deals intended to expand the acquisitive pharma giant’s R&D efforts into infectious disease—and which represent Lilly’s eighth, ninth, and 10th planned buyouts of smaller biotechs this year alone.

StrainX Bioworks nets $13m to scale biomanufacturing platform: ‘India is going to be the fermentation capital of the world’

Indian startup StrainX Bioworks has raised $13 million to scale a precision fermentation platform producing high-value n…

Making impact tire pressure visible

A series of live, side-by-side demonstrations showed how tire pressure and construction affect traction, slippage, soil behavior and overall operational efficiency. Similar demonstration formats in other European markets have already highlighted how strongly tire setup can influence efficiency. At a recently held Alliance Field Day in the UK, controlled comparisons showed fuel consumption differences of up to 20% depending on tire pressure and configuration. Building on this approach, the Sicily event focused on making these effects visible under local field conditions. The day was designed to make one thing clear: what happens in the soil when tire setup changes.

Guest article: Building the next generation of the global meat trade as a sovereign mandate

Editor’s note: Ahmed Bin Sulayem is the executive chairman and CEO of Dubai Multi Commodities Centre (DMCC). The v…

氟雷拉纳等13种化学物质列入农药管理,违规生产经营将按假农药论处

世界农化网中文网报道:2026年5月22日,农业农村部办公厅发布关于氟雷拉纳等化学物质特定用途管理认定的通知。